{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:50:58Z","timestamp":1792457458479,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.semarthrit.2025.152638","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:33:27Z","timestamp":1738334007000},"page":"152638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2546-312X","authenticated-orcid":false,"given":"Julia","family":"Spierings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta Del","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"van Rhenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152638_bib0001","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/1744666X.2019.1656526","article-title":"The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? an update on behalf of the EBMT autoimmune diseases working party","volume":"15","author":"Snowden","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0002","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41409-021-01326-6","article-title":"Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations","volume":"56","author":"Greco","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0003","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"Van Laar","year":"2014","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0004","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJMoa1703327","article-title":"Autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0005","first-page":"S198","article-title":"Autologous stem cell transplantation in systemic sclerosis: a systematic review","volume":"35","author":"Host","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0006","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.15993","article-title":"Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature","volume":"178","author":"Eyraud","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0007","series-title":"Autologous hematopoietic stem cell transplantation in systemic sclerosis: a reset to tolerance? vol. 195","author":"van Rhijn-Brouwer","year":"2018"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0008","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study","volume":"79","author":"Van Bijnen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42358-021-00166-8","article-title":"Hematopoietic stem cell transplantation for systemic sclerosis: brazilian experience","volume":"61","author":"Henrique-Neto","year":"2021","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044483","article-title":"A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol","volume":"11","author":"Spierings","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941011","article-title":"Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis","volume":"13","author":"Kawashima-Vasconcelos","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03300-1","article-title":"Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome","volume":"26","author":"Pecher","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0013","unstructured":"EBMT ADWP prospective non-interventional Study: post-AHSCT management in SSC patients (NISSC-2). 2018 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03444805."},{"key":"10.1016\/j.semarthrit.2025.152638_bib0014","unstructured":"Scleroderma Treatment With Autologous Transplant (STAT) Study (STAT); 2011. https:\/\/clinicaltrials.gov\/study\/NCT01413100."},{"key":"10.1016\/j.semarthrit.2025.152638_bib0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0016","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European society for blood and marrow transplantation autoimmune disease working party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0017","article-title":"The 2024 british society for rheumatology guideline for management of systemic sclerosis","author":"Denton","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0018","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5152\/eurjrheum.2020.19187","article-title":"News and failures from recent treatment trials in systemic sclerosis","volume":"7","author":"Denton","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0019","article-title":"Second autologous haematopoietic stem cell transplantation in systemic sclerosis - A case report","volume":"58","author":"Van Rhijn-Brouwer","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925776","article-title":"Case report: a successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation","volume":"13","author":"Haverkort","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01570","article-title":"Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT ADWP, IEWP, and PDWP working parties","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2025.152638_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102476","article-title":"Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee","volume":"69","author":"Greco","year":"2024","journal-title":"EClinicalMedicine"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:52:05Z","timestamp":1741099925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":22,"alternative-id":["S0049017225000095"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152638","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152638"}}